Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemoradiotherapy and Surgery for Pancoast Tumors
NCT00002642Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 1995
- Primary completion
- Jan 2001
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Cisplatin micelle injection (HA132) and etoposide in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Primary endpoints: Feasibility of treatment regimen and Toxic effects. Started Apr 1995; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)etoposide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00002642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002642.